Related Experiment Videos
Tetrasomy 21 in megakaryoblastic leukemia
L Potocki1, P L Townes, B A Woda
1Department of Pathology, University of Massachusetts Medical Center, Worcester.
Cancer Genetics and Cytogenetics
|May 1, 1994
Summary
A child diagnosed with megakaryoblastic leukemia presented with profound anemia. This rare leukemia subtype was linked to tetrasomy 21, a unique chromosome abnormality.
Area of Science:
- Hematology
- Pediatric Oncology
- Cytogenetics
Background:
- Megakaryoblastic leukemia is a rare subtype of acute myeloid leukemia.
- Diagnosis relies on bone marrow morphology, cytochemistry, and immunophenotyping.
- Genetic abnormalities play a crucial role in leukemia development and prognosis.
Observation:
- A 23-month-old female presented with severe anemia.
- Bone marrow examination revealed megakaryoblastic leukemia.
- Analysis of blast cells identified tetrasomy 21 (an extra copy of chromosome 21).
Findings:
- Tetrasomy 21 was the sole clonal cytogenetic abnormality.
- The patient's constitutional karyotype was normal (46,XX).
- This indicates a de novo genetic event leading to leukemia.
Implications:
- Highlights the importance of cytogenetic analysis in pediatric leukemia.
- Tetrasomy 21 may be a specific risk factor or characteristic of certain megakaryoblastic leukemia cases.
- Further research is needed to understand the role of tetrasomy 21 in leukemogenesis.